全文获取类型
收费全文 | 8141篇 |
免费 | 571篇 |
国内免费 | 52篇 |
专业分类
耳鼻咽喉 | 217篇 |
儿科学 | 151篇 |
妇产科学 | 316篇 |
基础医学 | 1056篇 |
口腔科学 | 148篇 |
临床医学 | 723篇 |
内科学 | 1965篇 |
皮肤病学 | 134篇 |
神经病学 | 716篇 |
特种医学 | 251篇 |
外科学 | 1227篇 |
综合类 | 40篇 |
一般理论 | 5篇 |
预防医学 | 434篇 |
眼科学 | 193篇 |
药学 | 572篇 |
中国医学 | 23篇 |
肿瘤学 | 593篇 |
出版年
2023年 | 60篇 |
2022年 | 184篇 |
2021年 | 321篇 |
2020年 | 135篇 |
2019年 | 200篇 |
2018年 | 256篇 |
2017年 | 207篇 |
2016年 | 207篇 |
2015年 | 236篇 |
2014年 | 315篇 |
2013年 | 435篇 |
2012年 | 616篇 |
2011年 | 604篇 |
2010年 | 344篇 |
2009年 | 290篇 |
2008年 | 481篇 |
2007年 | 485篇 |
2006年 | 475篇 |
2005年 | 468篇 |
2004年 | 409篇 |
2003年 | 346篇 |
2002年 | 290篇 |
2001年 | 135篇 |
2000年 | 119篇 |
1999年 | 99篇 |
1998年 | 64篇 |
1997年 | 44篇 |
1996年 | 47篇 |
1995年 | 45篇 |
1994年 | 50篇 |
1993年 | 43篇 |
1992年 | 74篇 |
1991年 | 49篇 |
1990年 | 49篇 |
1989年 | 55篇 |
1988年 | 46篇 |
1987年 | 40篇 |
1986年 | 19篇 |
1985年 | 28篇 |
1984年 | 30篇 |
1982年 | 16篇 |
1981年 | 17篇 |
1980年 | 14篇 |
1979年 | 24篇 |
1978年 | 21篇 |
1976年 | 16篇 |
1974年 | 15篇 |
1971年 | 17篇 |
1969年 | 17篇 |
1967年 | 14篇 |
排序方式: 共有8764条查询结果,搜索用时 15 毫秒
31.
32.
Jacek Semenowicz Bogdan Koczy Przemys?aw Czuma Bart?omiej Pijet Tomasz Olszewski Roman Walo 《Chirurgia narzadów ruchu i ortopedia polska》2007,72(1):33-36
The Avantage double mobility press-fit cup was devised by Dr. Bousquet in the 70's to bring reasonable response to a problem of recurrent dislocation after total hip arthroplasty. The cup is attached to the femoral head by a bipolar polyethylene liner. The polyethylene liner moves freely inside a shiny--polished metal cup. The angular range of motion before impingement is increased by the mobility of the liner. The double connection (cup-liner, liner-head) reduces the stress on the metal cup and improve the stability of the prosthesis. The solution has proved to be efficient in reducing dislocation risk and maintains at the same time the appropriate range of motion. Between January 2004 and November 2005, 113 hip arthroplasties in 108 women with use of the double mobility cup were performed. The cemented version of the Avantage cup was inserted in 15 patients (mean age--76.9 years). Uncemented, HA coated implant was used in 98 patients (with mean age of 55 years). The mean follow-up was 20.4 months. No one patient was lost to follow-up. No postoperative dislocation was observed during follow-up. There was no unwanted leg lengthening greater than 1 cm. The Avantage cup may be indicated in any primary total hip arthroplasty especially in those with increased risk of postoperative dislocations. This cup enables a correct balance of the hip without a need of the unwanted lengthening of the leg. 相似文献
33.
34.
P Albinet J P Romanet M Mouillon I Zerdab P Gravagna J L Tayot D Dupont R Eloy 《Journal fran?ais d'ophtalmologie》1990,13(3):109-114
The authors describe their original epikeratoplasty technic without sutures which is compatible with the use of collagen IV lens. They describe the first four observations of primates operated on using this technic. At first the epithelium is removed at the cornea center and a trepanation is made of 4 mm diameter and 0.1 mm depth. The bottom of the trepanation is then cut horizontally, and the periphery of the lens is put in the cornea stroma. Later the epithelium will recover the collagen lens. The lens is perfectly set in the cornea. We don't use any suture and so we avoid astigmatism and neovascularisation. The follow-up consisted of biomicroscopic examination photography, specular microscopy, pachymetry, photokeratoscopy (Nidek System) tonometry and histology. Clinical observance showed a perfect lens tolerance. The cornea is immediately transparent and within a week epithelial cells recovered the lens of three animals out of four. The photokeratoscopy study proved the important cornea refraction modification. This technic is reversible and the lens can be exchanged. A study of histology has begun and already shows a pluristratified epithelium. Further studies will test the biomaterial stability and ultra structural relations between the collagen IV lens and epithelial cells. 相似文献
35.
36.
Norbert Rilinger Johannes Görich Reinhard Scharrer-Pamler Jochen Vogel Reinhard Tomczak Elmar Merkle Roman Sokiranski Hans-Jürgen Brambs 《Cardiovascular and interventional radiology》1997,20(4):263-267
Purpose To evaluate the clinical results of percutaneous transluminal rotational atherectomy in the treatment of peripheral vascular
disease.
Methods Rotational atherectomy was performed in 39 patients aged 39–87 years (mean 66.6 years). A total of 71 lesions (43 stenoses
and 28 occlusions) were treated in 40 limbs. Additional balloon angioplasty was required in 54% of lesions. Fifteen patients
(37.5%) presented in Fontaine stage II, 10 patients (25%) in Fontaine stage III and 15 patients (37.5%) in Fontaine stage
IV. Rotational atherectomy at 750 rpm was carried out over a 0.014-inch guidewire with continuous aspiration into a vacuum,
bottle. Follow-up angiography and color flow Doppler examinations were performed in 22 patients (23 limbs) after a mean period
of 6 months (range 2–14 months)
Results There was one primary technical failure. In 36 of 40 lesions there was a good angiographic result with residual stenoses in
less than 30%. In 70 lesions treated by rotational atherectomy, however, 54% showed residual stenoses of 30%–50% and these
cases required additional balloon angioplasty. The mean ankle-brachial index improved significantly (p<0.001), from 0.49 before the procedure to 1.01 after the procedure. A single distal embolus, related to primary recanalization,
occurred and there were two large inguinal hematomas. Cumulative clinical patency after 6 months was 83.8% and cumulative
angiographic patency after 6 months was 79.1%.
Conclusion Percutaneous rotational atherectomy is a promising approach for the treatment of chronic peripheral vascular disease. Further
prospective, randomized studies are necessary to compare percutaneous transluminal angioplasty with this new technical approach. 相似文献
37.
Edward Golec Sebastian Nowak Roman Go?dzialski Micha? Godyń 《Chirurgia narzadów ruchu i ortopedia polska》2003,68(3):185-189
In this paper the authors evaluate the long-term results of treatment for articular calcaneus fractures with Westhues method. This evaluation is performed with regard to triple measurement of B?hler's angle value and to subjective criteria. The clinical material from years 1985-2002 consists of 47 patients aged between 24 and 56 years (mean age 32 years) with articular calcaneus fractures--namely, 41 male patients (87.2%) and 6 female patients (12.8%). The follow-up examination was performed in 24 patients (51% of all patients), namely, in 23 male patients (48.8%) and in one female patient (2.2%). Minimum follow-up time was 12 months and maximum was 9 years. Acquired results suggest that Westhues method restores normal B?hler's angle value only in tongue-type calcaneous fractures. 相似文献
38.
HU-211 is a synthetic, non-psychotropic cannabinoid which acts as a non-competitive NMDA antagonist and antioxidant. We studied the drug's therapeutic window as well as its long-term effect on cognitive and motor functions in a model of closed head injury (CHI) in the rat. A weight-drop device was used to induce CHI in ether anesthetized male rats. HU-211 (5 mg/kg) was administered i.v. to the experimental groups. For the therapeutic window study, drug was injected at 4 or 6 h after CHI. Edema (water content) and clinical status (neurological severity score, NSS) were evaluated at 24 h. Reduction of edema was slight, whereas improvement of NSS was significant when the drug was administered at 4 or 6 h (P = 0.0023and0.059, respectively). To determine the drug's long-term effect, it was administered 1 h after CHI and additional doses were later given. NSS was evaluated for a period of 30 d. A single dose of HU-211 given 1 h post-CHI improved the clinical outcome during the 30 d period (P < 0.01). Repetitive doses of HU-211 injected during the post traumatic period had similar effects. Cognitive functions were evaluated in the Morris water maze, with rats trained either before or after CHI. CHI resulted in a highly significant impairment of these abilities, whereas HU-211 treatment 1 h after CHI improved performance. Our results indicate that HU-211 is a potent cerebroprotective agent, with a therapeutic window of about 4 h. The beneficial response obtained even after a single dose was long lasting, and ameliorated impairment of both motor and cognitive functions following CHI. 相似文献
39.
Danuta Knapikowa Zbigniew Andreasik Stefan Kwiatkowski Marek Okrojek Roman Smolik Krzysztof Szczerba 《International archives of occupational and environmental health》1988,60(5):351-353
Summary We examined 81 men exposed for a long time to carbon disulphide (CS2) and tested the possible electrocardiographic (ECG) changes of ischemic heart disease (I.H.D.). The subjects were examined twice in two years. In order to make the ECG evaluation more objective, the Minnesota Code was applied. Two obligatory ECG examinations and only one submaximal effort test were carried out. For comparative evaluation, the control group was examined once. We proved that, in spite of the accepted opinion concerning the atheromatous action of CS2, this compound does not cause ECG symptoms of I.H.D. in a higher percentage of exposed persons. It also does not cause any significant increase in I.H.D. symptoms in dynamic ECG observations. 相似文献
40.
S Savastano G P Feltrin D Miotto M Chiesura-Corona A Torraco L Castellan E Roman A B el Khatib F Cannito P Sandri 《La Radiologia medica》1992,84(5):608-612
This study was aimed at evaluating the efficacy of chemoembolization (CE) to improve survival in patients with hepatocellular carcinoma (HCC). Our results were compared with the natural history of HCC. Sixty-two consecutive patients with HCC in Okuda's stages I and II underwent CE. Forty-seven patients were treated with CE alone; 9 patients had CE prior to surgery, and 6 patients had it after surgery because of recurrent HCC. One hundred and nine CEs (mean: 1.8 CEs/patient) were performed with Lipiodol UF, epirubicin and gelatin sponge. Actuarial survival was calculated considering Okuda's stage, neoplasm size, and evidence of pseudocapsule. The mean cumulative survival of the 47 patients treated with CE alone was 13.2 months; survival (+/- SE) at 12, 24 and 36 months was 0.75 (+/- 0.07), 0.46 (+/- 0.10) and 0.28 (+/- 0.12). Survival was not affected by Okuda's stage, neoplasm size, evidence of pseudocapsule (p > 0.05). Nevertheless, the patients with early HCC had better prognosis. Eighteen patients (42.9%) died during follow-up, 12 of whom (66.7%) from hepatic failure. The mean survival of patients with recurrence of HCC after surgery was 41 months (range: 24.8-74.9 months) since initial diagnosis of HCC, and 14.8 months (range: 7.1-29.6 months) since diagnosis of recurrence. Two of these patients died from hepatic failure. All the patients who underwent also surgery after CE are still alive (mean survival: 14.7 months). Histologic findings of resected specimens revealed viable neoplastic cells in all cases. Twenty-one major complications (20.2%) occurred in 18 patients (29%); the outcome of complications was favorable in all but one patient who died from sepsis. CE is a reliable and safe treatment for unresectable HCC. Small HCCs should be preferably treated with surgery or, alternatively, with percutaneous alcohol injection. 相似文献